Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nanogen Aktigel
20033000001
|
Nanogen Aktigel | Wound Management & Other Dressings | Dressings | No data available |
|
Nanogen Aktiv dressing 10cm x 10cm
20033000006
|
Nanogen Aktiv dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
Nanogen Aktiv dressing 10cm x 20cm
20033000007
|
Nanogen Aktiv dressing 10cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Nanogen Aktiv dressing 3cm x 3cm
20033000003
|
Nanogen Aktiv dressing 3cm x 3cm | Wound Management & Other Dressings | Dressings | No data available |
|
Nanogen Aktiv dressing 5cm x 5cm
20033000004
|
Nanogen Aktiv dressing 5cm x 5cm | Wound Management & Other Dressings | Dressings | No data available |
|
Nanogen Aktiv dressing 8cm x 8cm
20033000005
|
Nanogen Aktiv dressing 8cm x 8cm | Wound Management & Other Dressings | Dressings | No data available |
|
Nanova therapy multi-dressing kit 18cm x 14cm
20032100122
|
Nanova therapy multi-dressing kit 18cm x 14cm | Wound Management & Other Dressings | Dressings | No data available |
|
Nanova therapy multi-dressing kit 18cm x 18cm
20032100106
|
Nanova therapy multi-dressing kit 18cm x 18cm | Wound Management & Other Dressings | Dressings | No data available |
|
Nanova therapy multi-dressing kit 18cm x 28cm
20032100123
|
Nanova therapy multi-dressing kit 18cm x 28cm | Wound Management & Other Dressings | Dressings | No data available |
|
Nanova therapy system starter kit 18cm x 18cm
20032100105
|
Nanova therapy system starter kit 18cm x 18cm | Wound Management & Other Dressings | Dressings | No data available |
|
Napratec OP tablets
1001010P0BKAAAL
|
Napratec | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naprosyn 125mg/5ml oral suspension
1001010P0BCACAR
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naprosyn 500mg suppositories
1001010P0BCADBG
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naprosyn Pain Relief 250mg gastro-resistant tablets
1001010P0BCAKAH
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naprosyn S/R 500mg tablets
1001010P0BCAJAQ
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 100mg/5ml oral suspension
1001010P0AAAYAY
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 320mg/5ml oral suspension
1001010P0AABIBI
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 500mg modified-release tablets
1001010P0AAAQAQ
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 500mg suppositories
1001010P0AABGBG
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 500mg tablets and Misoprostol 200microgram tablets
1001010P0AAALAL
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 500mg/5ml oral suspension
1001010P0AAATAT
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 60mg/5ml oral suspension
1001010P0AABHBH
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 70mg/5ml oral suspension
1001010P0AAAWAW
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 75mg/5ml oral suspension
1001010P0AAAZAZ
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen sodium 275mg tablets
100101070AAAAAA
|
Naproxen sodium | Naproxen sodium | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.